CV Sciences appoints Dr. Jamie Corroon Jr. to board; Dr. Maroon resigns

CV Sciences, Inc.

Dr. Jamie Corroon Jr. appointed to Board of Directors effective July 21, 2022.
Dr. Corroon served on Medical Advisory Board since 2020; background in naturopathic medicine and cannabis.
Dr. Joseph C. Maroon resigned same day; resignation not due to any disagreement with the company.
Dr. Corroon will hold office until next stockholder election of directors.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Joseph C. Maroon

Director

CVSI · CV Sciences, Inc.

Effective: 2022-07-21
Filed: July 27, 2022, 7:59 PM ET

On July 21, 2022, Dr. Joseph C. Maroon resigned as a member of the Board of Directors of the Company.

Appointed

Dr. Jamie Corroon Jr.

Director

CVSI · CV Sciences, Inc.

Effective: 2022-07-21
Filed: July 27, 2022, 7:59 PM ET

On July 21, 2022, the Board of Directors of CV Sciences, Inc. (the "Company") appointed Dr. Jamie Corroon Jr., ND, MPH as a director on the Company’s Board of Directors (the “Board”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Joseph C. Maroon resigned as Director at CV Sciences, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 21, 2022, Dr. Joseph C. Maroon resigned as a member of the Board of Directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Jamie Corroon Jr. was appointed as Director at CV Sciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 21, 2022, the Board of Directors of CV Sciences, Inc. (the "Company") appointed Dr. Jamie Corroon Jr., ND, MPH as a director on the Company’s Board of Directors (the “Board”).

View on SEC.gov

CV Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001510964-22-000058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.